Workflow
柳药集团(603368) - 2023 Q3 - 季度财报
LZYYLZYY(SH:603368)2023-10-25 16:00

Financial Performance - The company's revenue for Q3 2023 reached CNY 5.27 billion, representing a year-on-year increase of 5.02%[4] - Net profit attributable to shareholders for Q3 2023 was CNY 231.60 million, up 12.32% compared to the same period last year[4] - For the first nine months of 2023, the company achieved a total revenue of CNY 15.62 billion, a growth of 9.80% year-on-year[8] - The net profit attributable to shareholders for the first nine months was CNY 674.58 million, reflecting a year-on-year increase of 17.26%[8] - Total operating revenue for the first three quarters of 2023 reached CNY 15,616,596,259.20, an increase of 9.8% compared to CNY 14,222,353,645.12 in the same period of 2022[26] - Net profit for the first three quarters of 2023 was CNY 719,540,098.92, representing a 18.7% increase from CNY 606,041,757.14 in the same period of 2022[28] - The company reported a total profit of CNY 841,749,229.83 for the first three quarters of 2023, compared to CNY 705,254,116.41 in 2022[27] - Earnings per share for the first three quarters of 2023 was CNY 1.86, compared to CNY 1.59 in the same period of 2022[28] Segment Performance - The wholesale segment contributed CNY 1.27 billion in revenue for Q3 2023, with a year-on-year growth of 9.81%[11] - The retail segment reported a slight decline in revenue, totaling CNY 205.63 million, down 1.21% year-on-year[11] - The industrial segment saw significant growth, with revenue increasing by 51.37% to CNY 76.76 million in Q3 2023[11] Cash Flow and Liquidity - The company's cash flow from operating activities increased by 88.72% year-to-date, primarily due to higher sales collections[14] - Cash inflow from operating activities for the first three quarters of 2023 was CNY 16,916,527,014.07, an increase from CNY 14,102,434,755.76 in 2022[29] - Cash outflow from operating activities for the first three quarters of 2023 totaled CNY 16,897,013,115.71, compared to CNY 14,092,094,719.97 in 2022[29] - The net cash flow from operating activities for Q3 2023 was ¥19,513,898.36, compared to ¥10,340,035.79 in Q3 2022, indicating an increase[30] - The total cash and cash equivalents at the end of Q3 2023 stood at ¥2,008,554,909.18, down from ¥3,039,360,326.43 at the end of Q3 2022[32] - The beginning cash and cash equivalents balance for Q3 2023 was ¥2,653,633,054.81, down from ¥3,261,760,273.40 in Q3 2022[32] Assets and Liabilities - The total assets at the end of Q3 2023 amounted to CNY 20.74 billion, an increase of 11.45% from the end of the previous year[6] - Current assets amounted to CNY 18.31 billion, up from CNY 16.13 billion at the end of 2022, indicating a growth of about 13.5%[23] - Accounts receivable increased to CNY 11.32 billion from CNY 8.71 billion, representing a significant rise of approximately 29.1%[22] - Inventory levels rose to CNY 2.70 billion, compared to CNY 2.46 billion at the end of 2022, marking an increase of around 9.7%[23] - Current liabilities totaled CNY 12.41 billion, up from CNY 10.83 billion, which is an increase of about 14.6%[24] - The total liabilities as of the end of the reporting period were CNY 13,857,156,611.29, an increase from CNY 12,241,643,740.63 in the previous year[25] - Total equity increased to CNY 6,879,508,368.43 from CNY 6,365,347,906.28 year-on-year[25] Strategic Focus - The company is focused on expanding its market presence and enhancing product development strategies to drive future growth[19]